首页> 外文期刊>Vaccine >The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays
【24h】

The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays

机译:The second HPV serology meeting: Progress and challenges in standardization of human papillomavirus serology assays

获取原文
获取原文并翻译 | 示例
           

摘要

© 2023The HPV Serology Laboratory in the Frederick National Laboratory for Cancer Research is working in partnership with the scientific community with the goal of standardizing and harmonizing current HPV serology assay platforms in response to the increasing number of immunobridging trials relying on serology data for approval of new vaccine dosing schedules and new formulations. A virtual meeting was held on June 29–30, 2021, to review the progress of the standardization initiative thus far and to bridge scientific gaps and outstanding questions. The main aims and outcomes of the meeting were to discuss: 1) standardization of assays and reagents; 2) International Standard calibration procedures; 3) assay cut-off values; 4) current immunobridging clinical trials; and 5) gaps and challenges in standardization of HPV serology.

著录项

  • 来源
    《Vaccine》 |2023年第6期|1177-1181|共5页
  • 作者单位

    HPV Immunology and HPV Serology Laboratories Frederick National Laboratory for Cancer Research;

    Division of High-Consequence Pathogens and Pathology National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 医学免疫学;
  • 关键词

    HPV; Serology; Standardization;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号